BCM Locks in Brazilian Reagent Plant to Secure Ema Rare Earth Project Supply Chain
Key Takeaways
- BCM has executed a binding agreement to acquire a 90% interest in Sais Nordeste, an established Brazilian magnesium sulphate producer, for a nominal cash consideration of R$1 — magnesium sulphate is the principal leaching reagent for the Ema ISR process.
- Initial production capacity is expected to supply approximately 50% of Ema's magnesium sulphate requirements, with potential to scale beyond 100% of the project's forecast needs.
- The acquisition targets a financially restructured but operationally functional plant — Sais Nordeste entered Brazil's Chapter 11 equivalent in February 2026 due to financial obligations, not operational failure.
- Legacy liabilities are estimated at R$15.3M (~A$4.2M), repayable over a majority 10-year period, making the real economic commitment the restructuring funding rather than an upfront vendor payment.
- BCM has simultaneously secured local Brazilian supply agreements for magnesium oxide and sulphuric acid — the two raw materials used to produce magnesium sulphate — creating a vertically integrated supply corridor within Bahia.
BCM moves upstream to lock in Ema’s critical reagent supply
Brazilian Critical Minerals Limited (ASX: BCM), through its wholly owned Brazilian subsidiary Mineração BBX do Brasil Ltda (BBX), has executed a binding agreement to acquire a 90% interest in Sais Nordeste Indústria e Comércio Ltda, an established magnesium sulphate producer located in Feira de Santana, Bahia, Brazil. Magnesium sulphate is the principal leaching reagent proposed for the Ema Rare Earth Project’s in-situ recovery (ISR) process, making this acquisition a direct de-risking action for the entire project.
BCM has also secured local Brazilian supply agreements for magnesium oxide (MgO) and sulphuric acid (H₂SO₄), the two principal raw materials used to produce magnesium sulphate. The strategic context matters: during 2026, China’s export controls have increasingly extended beyond finished rare earth products into the equipment, consumables and technical capabilities required to develop rare earth projects themselves. Initial production capacity is expected to supply approximately 50% of Ema’s magnesium sulphate requirements, with potential to supply more than 100% of the project’s forecast requirements.
When big ASX news breaks, our subscribers know first
Why magnesium sulphate is the linchpin of the Ema Project
In-situ recovery (ISR) is a mining technique where a leaching solution is injected directly into mineralised clay to dissolve rare earth elements in place, removing the need for conventional open-pit mining. At Ema, that leaching solution is magnesium sulphate. The recovered solution is then processed to produce Mixed Rare Earth Carbonate (MREC), which is the product BCM intends to supply into the ex-China rare earth separation and refining industry.
This is why reagent security is not a secondary consideration. If magnesium sulphate supply is unreliable, interrupted, or controlled by a foreign supply chain, Ema cannot produce MREC. There is no workaround. Controlling this input upstream is, therefore, a direct prerequisite to the entire project generating revenue.
BCM’s move to acquire a domestic Brazilian production platform addresses that dependency head-on. Rather than relying on third-party or imported supply, the company is establishing access to an existing manufacturing platform within Brazil’s own industrial corridor.
The Sais Nordeste acquisition — structure, location and strategic advantages
An established platform, not a greenfield build
Sais Nordeste brings more than five decades of magnesium sulphate manufacturing knowledge, established supplier relationships and existing industrial infrastructure in Feira de Santana, Bahia. The plant was fully operational until February 2026, when Sais Nordeste entered the Brazilian Bankruptcy and Reorganization Law (Law 11.101/05), comparable to Chapter 11 of the United States Bankruptcy Code, after becoming unable to meet its financial obligations.
Critically, the filing arose despite strong plant utilisation and continued demand for its products. This was a financial restructuring situation, not an operational failure. BCM is acquiring a functioning industrial platform for a nominal cash consideration of R$1, rather than funding a greenfield build from scratch.
Location and integrated supply chain
The plant’s location within Bahia creates a vertically integrated supply corridor. Sulphuric acid is supplied from UNIGEL at the Camaçari industrial complex, approximately 80km from the plant. Magnesium oxide is sourced from Bahia’s established magnesite and MgO industry centred on Brumado, approximately 560km from the processing plant. Salvador’s deepwater port sits approximately 100km away, providing access to global markets.
The five strategic advantages flagged in the announcement are:
- Integrated supply chain within Bahia
- Proximity to raw material sources
- Access to port infrastructure
- Strong road network connectivity
- Cost-competitive production platform
Transaction structure at a glance
| Term | Detail |
|---|---|
| Acquisition interest | 90% |
| Cash consideration | R$1 (nominal) |
| Legacy liabilities (estimated) | R$15.3M (~A$4.2M) |
| Repayment structure | Majority scheduled over a 10-year period |
| Remaining interest | 10% retained by existing shareholder |
Formal transfer of the 90% interest to BBX occurs at completion, once conditions precedent are satisfied and the required judicial, regulatory and corporate approvals under the Judicial Recovery process are obtained.
MD Andrew Reid on building Ema’s supply chain resilience
Andrew Reid, Managing Director
“Magnesium sulphate is the principal leaching reagent proposed for our ISR success story. Securing an established Brazilian production platform for this critical reagent gives BCM the opportunity to build greater control and resilience into the Ema supply chain and materially reduce our exposure to third-party reagent supply. Stage 1 production capacity is expected to supply approximately 50% of the Ema MGSUL needs over the first few years of production. We view this as a strategic upstream investment that is at least as important to Ema as downstream integration…”
BCM’s stated position is that upstream reagent security is a prerequisite to supplying the emerging ex-China rare earth separation and refining industry. The logic is sequential: Ema must first reliably produce MREC before it can function as a supplier into that market. Securing the principal ISR reagent is fundamental to achieving that objective.
The next major ASX story will hit our subscribers first
Restructuring pathway and next steps
BCM will immediately commence funding and overseeing the financial and operational restructuring of Sais Nordeste under documented financing arrangements, while existing management remains formally responsible for the company during this phase. An engineering design and modifications assessment has already commenced to determine the work required to adapt the plant to Ema’s specific needs.
For investors, the economic commitment here is the funding required to return Sais Nordeste to sustainable operations, rather than a material upfront cash payment to vendors. The key steps ahead are:
- Financial restructuring — treatment and renegotiation of Federal and State tax liabilities (estimated R$15.3M / ~A$4.2M)
- Engineering modifications assessment to adapt the plant to Ema’s requirements
- Return of the plant to sustainable commercial operations
- Satisfaction of conditions precedent and judicial, regulatory and corporate approvals
- Formal transfer of the 90% interest to BBX at completion
This upstream strategy complements BCM’s objective of producing MREC at Ema for supply into a rare earth separation and refining industry being progressively established outside China. By controlling both the raw material supply agreements and the production platform for its principal leaching reagent, BCM is building the supply chain foundation that MREC production depends upon.
For investors wanting to understand the full financial context behind this upstream investment, our deep-dive into the Ema BFS economics covers the project’s US$1.47B NPV, capital cost structure, and the low-capex development pathway that makes reagent cost control a material lever on project returns.
Don’t Miss the Next Rare Earths Breakthrough on ASX
Get FREE breaking ASX rare earths and critical minerals news delivered to your inbox within minutes of release, complete with in-depth analysis. Join 30,000+ subscribers already staying ahead of the market. Click the “Free Alerts” button at Discovery Alert to receive the moment market-moving announcements drop.